Has your company recently designed, built or renovated a state-of-the-art pharmaceutical or biotechnology facility that is best in its class?
ISPE’s Facility of the Year Awards Program is the premier global awards program recognizing innovation and creativity in the pharmaceutical and biotechnology manufacturing industries. The FOYA program showcases accomplishments in facility design, construction, and operation. It celebrates the shared commitment and dedication of individuals working for different companies worldwide to enhance patient health and safety through innovation and advancements in pharmaceutical and biotechnology manufacturing.
Projects selected for these prestigious awards set the standard for pharmaceutical facilities by demonstrating excellence in the categories of:
- Innovation
- Operations
- Supply Chain
- Pharma 4.0™
- Social Impact
How to Submit Your Facility
- Review the 2026 FOYA Program Guide and Submission Instructions
- Draft your Project Submission Document (guidelines listed in the 2026 FOYA Program Information document)
- Complete the online FOYA Submission Form:
steps to complete the online FOYA sumbmission form | |
---|---|
Complete Form Sections | |
Contact Information | |
General Project Information | |
Key Project Participants | |
Project Size & Type | |
Project Provisions | |
Acknowledgment & Upload the following | |
Program Entry Form | |
Applicant Release Form | |
Photography Release Form | |
Project Submission Document | |
9 Project Photos | |
Payment | |
Submit payment for the 2026 ISPE FOYA Project Submission |
Note, you will be able to save a draft of your submission form. This draft will stay active for 14 days.
Submittal Deadline is Friday, 5 December 2025
ISPE FOYA Submission Best Practices
Watch this insightful webinar focused on the Facility of the Year Awards (FOYA) submission process.
Facility of the Year Awards Eligibility
Building Types
- Manufacturing-Based Projects
GMP manufacturing-based projects consisting of buildings, equipment, systems, and manufacturing methodologies deployed to manufacture regulated pharmaceutical drug substances, drug products, medical devices, combination products, and other commercial entities under the purview of the US FDA, and other global regulatory bodies.
In addition, non-regulated facilities that meet the criteria listed above may also be eligible if demonstration is provided to indicate they are operated within similar GMP guidelines. - Process Development Projects
Project examples may include laboratories, pilot plants, medical device production, fill/finish, packaging facilities, and other similar process development facilities that may or may not be regulated. Submissions will be primarily judged on the merits of the applied innovation as it pertains to the development of pharmaceutical and biotechnology products.